David J Argyle
Overview
Explore the profile of David J Argyle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Djikeng A, Argyle D, Morrison L, de C Bronsvoort B
Am J Vet Res
. 2022 Dec;
84(1).
PMID: 36534537
No abstract available.
2.
Pang L, Cervantes-Arias A, Else R, Argyle D
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077879
In the original article [...].
3.
Ward C, Meehan J, Gray M, Murray A, Argyle D, Kunkler I, et al.
Explor Target Antitumor Ther
. 2022 Sep;
1(2):71-100.
PMID: 36046070
Dysregulation of cellular pH is frequent in solid tumours and provides potential opportunities for therapeutic intervention. The acidic microenvironment within a tumour can promote migration, invasion and metastasis of cancer...
4.
Ferrari G, Pang L, de Moliner F, Vendrell M, Reardon R, Higgins A, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205831
Bleomycin is a chemotherapy agent that, when administered systemically, can cause severe pulmonary toxicity. Bleosome is a novel formulation of bleomycin encapsulated in ultra-deformable (UD) liposomes that may be applicable...
5.
Payton C, Pang L, Gray M, Argyle D
J Pers Med
. 2021 Dec;
11(12).
PMID: 34945782
Radiation resistance is a significant challenge in the treatment of breast cancer in humans. Human breast cancer is commonly treated with surgery and adjuvant chemotherapy/radiotherapy, but recurrence and metastasis upon...
6.
Ikeh K, Lamkin E, Crompton A, Deutsch J, Fisher K, Gray M, et al.
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771454
Cancer therapy resistance is a persistent clinical challenge. Recently, inhibition of the mutagenic translesion synthesis (TLS) protein REV1 was shown to enhance tumor cell response to chemotherapy by triggering senescence...
7.
Gonzalez-Fernandez E, Staderini M, Marland J, Gray M, Ucar A, Dunare C, et al.
Biosens Bioelectron
. 2021 Nov;
197:113728.
PMID: 34763151
The development of robust implantable sensors is important in the successful advancement of personalised medicine as they have the potential to provide in situ real-time data regarding the status of...
8.
Silveira T, Pang L, Di Domenico A, Veloso E, Silva I, Del Puerto H, et al.
Front Vet Sci
. 2021 Sep;
8:633170.
PMID: 34513965
Metastatic melanoma is a very aggressive form of cancer in both humans and dogs. Dogs primarily develop oral melanoma of mucosal origin. Although oral melanoma in humans is rare, both...
9.
Marland J, Gray M, Argyle D, Underwood I, Murray A, Potter M
Micromachines (Basel)
. 2021 Aug;
12(7).
PMID: 34357220
Anastomotic leakage (AL) is a common and dangerous post-operative complication following intestinal resection, causing substantial morbidity and mortality. Ischaemia in the tissue surrounding the anastomosis is a major risk-factor for...
10.
Gray M, Marland J, Murray A, Argyle D, Potter M
J Pers Med
. 2021 Jun;
11(6).
PMID: 34070593
Development of an anastomotic leak (AL) following intestinal surgery for the treatment of colorectal cancers is a life-threatening complication. Failure of the anastomosis to heal correctly can lead to contamination...